Literature DB >> 28398689

Facial diplegia after pembrolizumab treatment.

Micah D Yost1, Claudia Z Chou1, Hugo Botha1, Matthew S Block2, Teerin Liewluck1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28398689     DOI： 10.1002/mus.25663

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


× No keyword cloud information.
  5 in total

Review 1.  Neurological Complications of Therapeutic Monoclonal Antibodies: Trends from Oncology to Rheumatology.

Authors:  Chandler Gill; Stasia Rouse; Ryan D Jacobson
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-17       Impact factor: 5.081

2.  Third Cranial Nerve Palsy after Monoclonal Antibody Therapy for Lung Cancer: A Case Report.

Authors:  Paolo Missori; Angela Ambrosone; Leonardo Cristofani; Francesco Fattapposta; Antonio Currà
Journal:  Case Rep Ophthalmol       Date:  2022-04-21

Review 3.  Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors.

Authors:  Justin C Kao; Adipong Brickshawana; Teerin Liewluck
Journal:  Curr Neurol Neurosci Rep       Date:  2018-08-04       Impact factor: 5.081

Review 4.  Neurologic Toxicity of Immune Checkpoint Inhibitors: A Review of Literature.

Authors:  Víctor Albarrán; Jesús Chamorro; Diana Isabel Rosero; Cristina Saavedra; Ainara Soria; Alfredo Carrato; Pablo Gajate
Journal:  Front Pharmacol       Date:  2022-02-14       Impact factor: 5.810

Review 5.  Immune Checkpoint Inhibitors and Neurotoxicity.

Authors:  Zhiyi Zhao; Chunlin Zhang; Lian Zhou; Pan Dong; Lei Shi
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.